Loading…

Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents

[Display omitted] •Virtual screening to discover potential nucleic acids intercalators.•Two hits active against Vaccinia virus were found.•Intercalating mechanism was proposed for the hits. This paper describes computer-aided design of new anti-viral agents against Vaccinia virus (VACV) potentially...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2017-08, Vol.27 (16), p.3915-3919
Main Authors: Klimenko, Kyrylo, Lyakhov, Sergey, Shibinskaya, Marina, Karpenko, Alexander, Marcou, Gilles, Horvath, Dragos, Zenkova, Marina, Goncharova, Elena, Amirkhanov, Rinat, Krysko, Andrei, Andronati, Sergei, Levandovskiy, Igor, Polishchuk, Pavel, Kuz'min, Victor, Varnek, Alexandre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c390t-a8c043304fc94a7927d3eedbf46268e6b83f1d453a4b484b4ddfe0c9314412373
cites cdi_FETCH-LOGICAL-c390t-a8c043304fc94a7927d3eedbf46268e6b83f1d453a4b484b4ddfe0c9314412373
container_end_page 3919
container_issue 16
container_start_page 3915
container_title Bioorganic & medicinal chemistry letters
container_volume 27
creator Klimenko, Kyrylo
Lyakhov, Sergey
Shibinskaya, Marina
Karpenko, Alexander
Marcou, Gilles
Horvath, Dragos
Zenkova, Marina
Goncharova, Elena
Amirkhanov, Rinat
Krysko, Andrei
Andronati, Sergei
Levandovskiy, Igor
Polishchuk, Pavel
Kuz'min, Victor
Varnek, Alexandre
description [Display omitted] •Virtual screening to discover potential nucleic acids intercalators.•Two hits active against Vaccinia virus were found.•Intercalating mechanism was proposed for the hits. This paper describes computer-aided design of new anti-viral agents against Vaccinia virus (VACV) potentially acting as nucleic acid intercalators. Earlier obtained experimental data for DNA intercalation affinities and activities against Vesicular stomatitis virus (VSV) have been used to build, respectively, pharmacophore and QSAR models. These models were used for virtual screening of a database of 245 molecules generated around typical scaffolds of known DNA intercalators. This resulted in 12 hits which then were synthesized and tested for antiviral activity against VaV together with 43 compounds earlier studied against VSV. Two compounds displaying high antiviral activity against VaV and low cytotoxicity were selected for further antiviral activity investigations.
doi_str_mv 10.1016/j.bmcl.2017.06.035
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03151681v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X17306340</els_id><sourcerecordid>1915348000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-a8c043304fc94a7927d3eedbf46268e6b83f1d453a4b484b4ddfe0c9314412373</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVoSbZJ_kAOxccWamdkybINvSxJ2hSW5JKWHgpClsYbLV4pleSF_Pto2TTHHoaBmW_ewHuEXFCoKFBxuamGrZ6qGmhbgaiANUdkQbngJePQvCML6AWUXc9_n5APMW4AKAfOj8lJ3QkhWsYW5M8vG9KspiLqgOisW38p4rNLjxhtLJQzxWD95NdWZwZ3appVst4Vfiyu75aFdQlDXuWhW2c82Z0NmVRrdCmekfejmiKev_ZT8vPbzcPVbbm6__7jarkqNeshlarTwBkDPuqeq7avW8MQzTByUYsOxdCxkRreMMUH3uUyZkTQPaOc05q17JR8Pug-qkk-BbtV4Vl6ZeXtciX3M2C0oaKjO5rZTwf2Kfi_M8YktzZqnCbl0M9R0p42jHcAkNH6gOrgYww4vmlTkPsE5EbuE5D7BCSI_KbJRx9f9edhi-bt5J_lGfh6ADA7srMYZNQWnUZjA-okjbf_038BL42XBw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1915348000</pqid></control><display><type>article</type><title>Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Klimenko, Kyrylo ; Lyakhov, Sergey ; Shibinskaya, Marina ; Karpenko, Alexander ; Marcou, Gilles ; Horvath, Dragos ; Zenkova, Marina ; Goncharova, Elena ; Amirkhanov, Rinat ; Krysko, Andrei ; Andronati, Sergei ; Levandovskiy, Igor ; Polishchuk, Pavel ; Kuz'min, Victor ; Varnek, Alexandre</creator><creatorcontrib>Klimenko, Kyrylo ; Lyakhov, Sergey ; Shibinskaya, Marina ; Karpenko, Alexander ; Marcou, Gilles ; Horvath, Dragos ; Zenkova, Marina ; Goncharova, Elena ; Amirkhanov, Rinat ; Krysko, Andrei ; Andronati, Sergei ; Levandovskiy, Igor ; Polishchuk, Pavel ; Kuz'min, Victor ; Varnek, Alexandre</creatorcontrib><description>[Display omitted] •Virtual screening to discover potential nucleic acids intercalators.•Two hits active against Vaccinia virus were found.•Intercalating mechanism was proposed for the hits. This paper describes computer-aided design of new anti-viral agents against Vaccinia virus (VACV) potentially acting as nucleic acid intercalators. Earlier obtained experimental data for DNA intercalation affinities and activities against Vesicular stomatitis virus (VSV) have been used to build, respectively, pharmacophore and QSAR models. These models were used for virtual screening of a database of 245 molecules generated around typical scaffolds of known DNA intercalators. This resulted in 12 hits which then were synthesized and tested for antiviral activity against VaV together with 43 compounds earlier studied against VSV. Two compounds displaying high antiviral activity against VaV and low cytotoxicity were selected for further antiviral activity investigations.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2017.06.035</identifier><identifier>PMID: 28666733</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antiviral activity ; Antiviral Agents - chemical synthesis ; Antiviral Agents - chemistry ; Antiviral Agents - pharmacology ; Cell Line ; Cell Survival - drug effects ; Chemical Sciences ; Cheminformatics ; DNA - drug effects ; DNA affinity ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Humans ; Microbial Sensitivity Tests ; Molecular Structure ; Quantitative Structure-Activity Relationship ; Structure-activity modeling ; Vaccinia virus ; Vesicular stomatitis Indiana virus - drug effects ; Virtual screening</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2017-08, Vol.27 (16), p.3915-3919</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-a8c043304fc94a7927d3eedbf46268e6b83f1d453a4b484b4ddfe0c9314412373</citedby><cites>FETCH-LOGICAL-c390t-a8c043304fc94a7927d3eedbf46268e6b83f1d453a4b484b4ddfe0c9314412373</cites><orcidid>0000-0003-1886-925X ; 0000-0003-1676-6708 ; 0000-0003-0173-5714</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28666733$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03151681$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Klimenko, Kyrylo</creatorcontrib><creatorcontrib>Lyakhov, Sergey</creatorcontrib><creatorcontrib>Shibinskaya, Marina</creatorcontrib><creatorcontrib>Karpenko, Alexander</creatorcontrib><creatorcontrib>Marcou, Gilles</creatorcontrib><creatorcontrib>Horvath, Dragos</creatorcontrib><creatorcontrib>Zenkova, Marina</creatorcontrib><creatorcontrib>Goncharova, Elena</creatorcontrib><creatorcontrib>Amirkhanov, Rinat</creatorcontrib><creatorcontrib>Krysko, Andrei</creatorcontrib><creatorcontrib>Andronati, Sergei</creatorcontrib><creatorcontrib>Levandovskiy, Igor</creatorcontrib><creatorcontrib>Polishchuk, Pavel</creatorcontrib><creatorcontrib>Kuz'min, Victor</creatorcontrib><creatorcontrib>Varnek, Alexandre</creatorcontrib><title>Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted] •Virtual screening to discover potential nucleic acids intercalators.•Two hits active against Vaccinia virus were found.•Intercalating mechanism was proposed for the hits. This paper describes computer-aided design of new anti-viral agents against Vaccinia virus (VACV) potentially acting as nucleic acid intercalators. Earlier obtained experimental data for DNA intercalation affinities and activities against Vesicular stomatitis virus (VSV) have been used to build, respectively, pharmacophore and QSAR models. These models were used for virtual screening of a database of 245 molecules generated around typical scaffolds of known DNA intercalators. This resulted in 12 hits which then were synthesized and tested for antiviral activity against VaV together with 43 compounds earlier studied against VSV. Two compounds displaying high antiviral activity against VaV and low cytotoxicity were selected for further antiviral activity investigations.</description><subject>Antiviral activity</subject><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - pharmacology</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Chemical Sciences</subject><subject>Cheminformatics</subject><subject>DNA - drug effects</subject><subject>DNA affinity</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Evaluation, Preclinical</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Molecular Structure</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Structure-activity modeling</subject><subject>Vaccinia virus</subject><subject>Vesicular stomatitis Indiana virus - drug effects</subject><subject>Virtual screening</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kUFr3DAQhUVoSbZJ_kAOxccWamdkybINvSxJ2hSW5JKWHgpClsYbLV4pleSF_Pto2TTHHoaBmW_ewHuEXFCoKFBxuamGrZ6qGmhbgaiANUdkQbngJePQvCML6AWUXc9_n5APMW4AKAfOj8lJ3QkhWsYW5M8vG9KspiLqgOisW38p4rNLjxhtLJQzxWD95NdWZwZ3appVst4Vfiyu75aFdQlDXuWhW2c82Z0NmVRrdCmekfejmiKev_ZT8vPbzcPVbbm6__7jarkqNeshlarTwBkDPuqeq7avW8MQzTByUYsOxdCxkRreMMUH3uUyZkTQPaOc05q17JR8Pug-qkk-BbtV4Vl6ZeXtciX3M2C0oaKjO5rZTwf2Kfi_M8YktzZqnCbl0M9R0p42jHcAkNH6gOrgYww4vmlTkPsE5EbuE5D7BCSI_KbJRx9f9edhi-bt5J_lGfh6ADA7srMYZNQWnUZjA-okjbf_038BL42XBw</recordid><startdate>20170815</startdate><enddate>20170815</enddate><creator>Klimenko, Kyrylo</creator><creator>Lyakhov, Sergey</creator><creator>Shibinskaya, Marina</creator><creator>Karpenko, Alexander</creator><creator>Marcou, Gilles</creator><creator>Horvath, Dragos</creator><creator>Zenkova, Marina</creator><creator>Goncharova, Elena</creator><creator>Amirkhanov, Rinat</creator><creator>Krysko, Andrei</creator><creator>Andronati, Sergei</creator><creator>Levandovskiy, Igor</creator><creator>Polishchuk, Pavel</creator><creator>Kuz'min, Victor</creator><creator>Varnek, Alexandre</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-1886-925X</orcidid><orcidid>https://orcid.org/0000-0003-1676-6708</orcidid><orcidid>https://orcid.org/0000-0003-0173-5714</orcidid></search><sort><creationdate>20170815</creationdate><title>Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents</title><author>Klimenko, Kyrylo ; Lyakhov, Sergey ; Shibinskaya, Marina ; Karpenko, Alexander ; Marcou, Gilles ; Horvath, Dragos ; Zenkova, Marina ; Goncharova, Elena ; Amirkhanov, Rinat ; Krysko, Andrei ; Andronati, Sergei ; Levandovskiy, Igor ; Polishchuk, Pavel ; Kuz'min, Victor ; Varnek, Alexandre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-a8c043304fc94a7927d3eedbf46268e6b83f1d453a4b484b4ddfe0c9314412373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antiviral activity</topic><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - pharmacology</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Chemical Sciences</topic><topic>Cheminformatics</topic><topic>DNA - drug effects</topic><topic>DNA affinity</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Evaluation, Preclinical</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Molecular Structure</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Structure-activity modeling</topic><topic>Vaccinia virus</topic><topic>Vesicular stomatitis Indiana virus - drug effects</topic><topic>Virtual screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klimenko, Kyrylo</creatorcontrib><creatorcontrib>Lyakhov, Sergey</creatorcontrib><creatorcontrib>Shibinskaya, Marina</creatorcontrib><creatorcontrib>Karpenko, Alexander</creatorcontrib><creatorcontrib>Marcou, Gilles</creatorcontrib><creatorcontrib>Horvath, Dragos</creatorcontrib><creatorcontrib>Zenkova, Marina</creatorcontrib><creatorcontrib>Goncharova, Elena</creatorcontrib><creatorcontrib>Amirkhanov, Rinat</creatorcontrib><creatorcontrib>Krysko, Andrei</creatorcontrib><creatorcontrib>Andronati, Sergei</creatorcontrib><creatorcontrib>Levandovskiy, Igor</creatorcontrib><creatorcontrib>Polishchuk, Pavel</creatorcontrib><creatorcontrib>Kuz'min, Victor</creatorcontrib><creatorcontrib>Varnek, Alexandre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klimenko, Kyrylo</au><au>Lyakhov, Sergey</au><au>Shibinskaya, Marina</au><au>Karpenko, Alexander</au><au>Marcou, Gilles</au><au>Horvath, Dragos</au><au>Zenkova, Marina</au><au>Goncharova, Elena</au><au>Amirkhanov, Rinat</au><au>Krysko, Andrei</au><au>Andronati, Sergei</au><au>Levandovskiy, Igor</au><au>Polishchuk, Pavel</au><au>Kuz'min, Victor</au><au>Varnek, Alexandre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2017-08-15</date><risdate>2017</risdate><volume>27</volume><issue>16</issue><spage>3915</spage><epage>3919</epage><pages>3915-3919</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted] •Virtual screening to discover potential nucleic acids intercalators.•Two hits active against Vaccinia virus were found.•Intercalating mechanism was proposed for the hits. This paper describes computer-aided design of new anti-viral agents against Vaccinia virus (VACV) potentially acting as nucleic acid intercalators. Earlier obtained experimental data for DNA intercalation affinities and activities against Vesicular stomatitis virus (VSV) have been used to build, respectively, pharmacophore and QSAR models. These models were used for virtual screening of a database of 245 molecules generated around typical scaffolds of known DNA intercalators. This resulted in 12 hits which then were synthesized and tested for antiviral activity against VaV together with 43 compounds earlier studied against VSV. Two compounds displaying high antiviral activity against VaV and low cytotoxicity were selected for further antiviral activity investigations.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28666733</pmid><doi>10.1016/j.bmcl.2017.06.035</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-1886-925X</orcidid><orcidid>https://orcid.org/0000-0003-1676-6708</orcidid><orcidid>https://orcid.org/0000-0003-0173-5714</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2017-08, Vol.27 (16), p.3915-3919
issn 0960-894X
1464-3405
language eng
recordid cdi_hal_primary_oai_HAL_hal_03151681v1
source ScienceDirect Freedom Collection 2022-2024
subjects Antiviral activity
Antiviral Agents - chemical synthesis
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
Cell Line
Cell Survival - drug effects
Chemical Sciences
Cheminformatics
DNA - drug effects
DNA affinity
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Humans
Microbial Sensitivity Tests
Molecular Structure
Quantitative Structure-Activity Relationship
Structure-activity modeling
Vaccinia virus
Vesicular stomatitis Indiana virus - drug effects
Virtual screening
title Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A45%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Virtual%20screening,%20synthesis%20and%20biological%20evaluation%20of%20DNA%20intercalating%20antiviral%20agents&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Klimenko,%20Kyrylo&rft.date=2017-08-15&rft.volume=27&rft.issue=16&rft.spage=3915&rft.epage=3919&rft.pages=3915-3919&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2017.06.035&rft_dat=%3Cproquest_hal_p%3E1915348000%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-a8c043304fc94a7927d3eedbf46268e6b83f1d453a4b484b4ddfe0c9314412373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1915348000&rft_id=info:pmid/28666733&rfr_iscdi=true